“Can a bootstrapped, vertically-focused clinic operating system win the global aesthetics and wellness market by combining EMR, payments, and AI without ever raising outside capital?”
Pabau began in 2012 as a UK clinic management CRM (originally named 'Webbier CRM'). Bootstrapped throughout its history, it grew organically to serve 3,500+ clinics across ~40 countries by 2025. The company made a major bet in 2020–2023 by rebuilding the entire product ('Pabau 2') from scratch, then layered in AI (Pabau Scribe, prescribing agent, letters agent) and embedded payments (Pabau Pay via Stripe, Klarna BNPL) to become a full clinical + financial operating system for aesthetics, wellness, and medical practices.
Pabau processes payments through Stripe and Stripe Connect.
Pabau's lending and capital products are provided by Klarna.
Pabau uses Stripe for FX and cross-border payouts.
Pabau integrates with Xero.
The Embedded Finance Index 2026 maps 4 layers in Pabau's stack: Payments / PSP (Stripe and Stripe Connect); Lending (Klarna and Klarna BNPL (Pay in instalments / Pay later) for clinic patients); FX & payouts (Stripe); Accounting (Xero).
Pabau was founded by William Brandham and is founded in 2012, headquartered in London, United Kingdom.
Pabau has raised Bootstrapped in total (latest round: None (bootstrapped)).
Get a read on where your own stack stands against Pabau and the rest of its category — what they built versus bought, which providers they use, and where the gaps in your own strategy and competitive set actually are.